MAK Capital Urges Evotec to List US Unit Valued Over €1 Billion
MAK Capital is pushing Evotec, a drug discovery company, to list its US unit, which is estimated to be worth over €1 billion.
Toate subiectele etichetate cu #evotec
MAK Capital is pushing Evotec, a drug discovery company, to list its US unit, which is estimated to be worth over €1 billion.